|
MYL12A expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.986400E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.391400E-01 |
| Normal-vs-Stage2 |
1.589810E-01 |
| Normal-vs-Stage3 |
1.092200E-01 |
| Normal-vs-Stage4 |
1.180210E-01 |
| Stage1-vs-Stage2 |
2.488400E-01 |
| Stage1-vs-Stage3 |
1.370360E-01 |
| Stage1-vs-Stage4 |
1.498990E-01 |
| Stage2-vs-Stage3 |
8.774400E-01 |
| Stage2-vs-Stage4 |
5.320600E-01 |
| Stage3-vs-Stage4 |
6.556000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.790200E-01 |
| Normal-vs-AfricanAmerican |
4.396000E-01 |
| Normal-vs-Asian |
1.478240E-01 |
| Caucasian-vs-AfricanAmerican |
7.225200E-01 |
| Caucasian-vs-Asian |
2.282800E-01 |
| AfricanAmerican-vs-Asian |
1.405170E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
3.254200E-01 |
| Normal-vs-Female |
3.301600E-01 |
| Male-vs-Female |
8.453000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.904590E-01 |
| Normal-vs-Extreme_Weight |
5.566000E-01 |
| Normal-vs-Obese |
3.515000E-01 |
| Normal-vs-Extreme_Obese |
9.281900E-02 |
| Normal_Weight-vs-Extreme_Weight |
3.686600E-01 |
| Normal_Weight-vs-Obese |
5.742600E-01 |
| Normal_Weight-vs-Extreme_Obese |
2.500000E-01 |
| Extreme_Weight-vs-Obese |
6.828800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
1.330830E-01 |
| Obese-vs-Extreme_Obese |
1.443040E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.284000E-01 |
| Normal-vs-Age(41-60Yrs) |
7.557200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.266990E-01 |
| Normal-vs-Age(81-100Yrs) |
3.139000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.290000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.226200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.367800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.955900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.164200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.409200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
9.517800E-01 |
| Normal-VS-Type2 PRCC |
1.672040E-02 |
| Normal-VS-KIRP CIMP |
8.560200E-01 |
| Normal-VS-Unclassified PRCC |
2.474600E-01 |
| Type1 PRCC-VS-Type2 PRCC |
2.01799999999253E-05 |
| Type1 PRCC-VS-KIRP CIMP |
8.586800E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.183040E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.107700E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.784640E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
4.912000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.599800E-02 |
| Normal-vs-N1 |
1.822620E-01 |
| Normal-vs-N2 |
3.661000E-01 |
| N0-vs-N1 |
3.736800E-01 |
| N0-vs-N2 |
9.783400E-01 |
| N1-vs-N2 |
6.024000E-01 |
|
|
